AWARE
Research type
Research Study
Full title
AWARE: A World-wide Antihistamine-Refractory Chronic Urticaria Patient Evaluation
IRAS ID
152221
Contact name
Alexander Marsland
Contact email
Clinicaltrials.gov Identifier
CCRN Reference number, CCRN2907
Research summary
This is a prospective observational study that will be collecting patient reported outcomes. The study aims to assess the disease burden of chronic urticaria and to record the therapies used in daily clinical practice in the UK and the impact they have on the quality of life and work productivity of individual patients. A maximum of 250 patients will be enrolled approximately 5-15 clinical sites.
REC name
East Midlands - Nottingham 1 Research Ethics Committee
REC reference
14/EM/1031
Date of REC Opinion
11 Jun 2014
REC opinion
Favourable Opinion